Skip to main content
Goldman Sachs and Morgan Stanley logos on a financial news screen, symbolizing the bar on Chinese investors from the Anthropi

Editorial illustration for Goldman, Morgan Stanley Bar Chinese Investors From Anthropic IPO

Goldman, Morgan Stanley Bar Chinese Investors From...

• 2 min read

Anthropic's IPO paperwork comes with a geographic asterisk. Bloomberg reported that banks handling the offering are turning away buy orders from mainland China and Hong Kong, with some people involved pointing to ITAR, the export control regime covering defense-related goods, as the reason. Anthropic declined to comment on the matter.

The offering itself is a sizable one. Goldman Sachs and Morgan Stanley are running the show, backed by 20 other banks, with shares set to price on November 18 and begin trading on Nasdaq under the ticker ANT.

The exclusion tracks with a company that has made its China policy a matter of record rather than quiet practice. Anthropic's products aren't sold in China or Hong Kong, and the company has spent recent months blocking Chinese-controlled firms from its AI services while chasing down workarounds that let those firms reach Claude Code anyway. It also published research tracing large-scale distillation attempts, roughly 16 million queries, back to DeepSeek, Moonshot, and MiniMax. The IPO restrictions land on top of that history.

Investors from mainland China and Hong Kong are being shut out of Anthropic's IPO, according to Bloomberg. Multiple banks have reportedly rejected buy orders from those regions or consider allocations unlikely, with some of the people involved citing ITAR, the US export control rules governing defense-related goods, as the reason.

Why this matters

This is a preview of what AI capital markets look like once national security logic fully merges with Wall Street underwriting. Goldman and Morgan Stanley aren't just pricing a hot AI stock, they're pre-screening investor nationality to manage ITAR exposure before Anthropic even starts trading on November 18. For founders building frontier models, the message is blunt: your cap table is now a compliance document, and geopolitics will shape who's allowed to own a piece of you long before any product ships into those markets.

Anthropic's products were never sold in China or Hong Kong, yet that didn't stop the exclusion from extending to investment dollars, not just customers. Expect this to become a template rather than an exception as other frontier labs go public or raise late-stage rounds. Researchers and engineers should also notice the signal: the US is treating advanced AI development itself as an export-controlled asset class, not just a software product.

The IPO pricing on Nasdaq under ANT will tell us whether that restriction dents demand or barely registers against investor appetite.

LIVE22:45OpenAI board member warns AI takeover of society could be months away